Lv1
15 积分 2021-10-07 加入
Loss of TIM4-Dependent Efferocytosis in Kupffer Cells Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
16小时前
待确认
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
1个月前
已完结
Elucidating pathway-selective biased CCKBR agonism for Alzheimer’s disease treatment
1个月前
已完结
Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
2个月前
已完结
Identification of membrane-type receptor for bile acids (M-BAR)
2个月前
已完结
Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier
6个月前
已完结
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
6个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
6个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
6个月前
已完结
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
6个月前
已完结
皖公网安备34019202002308
